ClinicalTrials.govpublic full text
Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H
myelodysplastic disorders, leukemia, multiple myeloma, plasma cell dyscrasia, lymphoproliferative disorders, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 839460
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.